Trinity capital inc. provides $40 million term loan to taysha gene therapies

Phoenix , dec. 19, 2023 /prnewswire/ -- trinity capital inc. (nasdaq: trin) ("trinity"), a leading provider of diversified financial solutions to growth-stage companies, today announced the commitment of $40 million in term loans to taysha gene therapies, inc. (nasdaq: tsha) ("taysha"), a clinical-stage gene therapy company, pursuant to a loan and security agreement dated november 13, 2023, by and among taysha, the lenders party thereto from time to time (the "lenders"), and trinity, as administrative agent and collateral agent for the lenders. taysha is focused on developing and commercializing aav-based gene therapies for the treatment of monogenic diseases of the central nervous system ("cns").
TSHA Ratings Summary
TSHA Quant Ranking